| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(00)05115-1 |
| P698 | PubMed publication ID | 11438135 |
| P50 | author | Ajit Lalvani | Q60730031 |
| P2093 | author name string | A Whelan | |
| J J Deeks | |||
| G Pasvol | |||
| M Latif | |||
| A V Hill | |||
| K A Wilkinson | |||
| A A Pathan | |||
| H Durkan | |||
| W H Reece | |||
| P2860 | cites work | Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Joint Tuberculosis Committee of the British Thoracic Society | Q24679389 |
| Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project | Q28145755 | ||
| Comparative genomics of BCG vaccines by whole-genome DNA microarray | Q29618558 | ||
| Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides | Q34004667 | ||
| Specific immune-based diagnosis of tuberculosis | Q34048117 | ||
| Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis | Q35603209 | ||
| The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods | Q39388568 | ||
| Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians | Q39555280 | ||
| Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. | Q39823872 | ||
| The tuberculin skin test | Q40716380 | ||
| Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. | Q40825071 | ||
| Rapid effector function in CD8+ memory T cells | Q41847748 | ||
| Diagnosing latent tuberculosis infection: the 100-year upgrade | Q44773225 | ||
| Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight | Q45015210 | ||
| Frost revisited: the modern epidemiology of tuberculosis | Q52439891 | ||
| Detection of Active Tuberculosis Infection by T Cell Responses to Early‐Secreted Antigenic Target 6‐kDa Protein and Culture Filtrate Protein 10 | Q58827877 | ||
| The epidemiology of tuberculosis infection in a closed environment | Q72022675 | ||
| Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells | Q73702459 | ||
| Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors | Q77714908 | ||
| P433 | issue | 9273 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | contact tracing | Q1128437 |
| Mycobacterium tuberculosis | Q130971 | ||
| P304 | page(s) | 2017-2021 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells | |
| P478 | volume | 357 |
| Q37635580 | A 100 year update on diagnosis of tuberculosis infection |
| Q61450316 | A GIS-Based Artificial Neural Network Model for Spatial Distribution of Tuberculosis across the Continental United States |
| Q37658363 | A clinical approach to paediatric tuberculosis in Canada |
| Q51021443 | A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients. |
| Q21562599 | A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children |
| Q33377055 | Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study. |
| Q34414046 | An Enhanced ELISPOT Assay for Sensitive Detection of Antigen-Specific T Cell Responses to Borrelia burgdorferi |
| Q34719407 | An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection |
| Q36518580 | An update on the diagnosis of tuberculosis infection |
| Q40086473 | Analysis of Factors Influencing Diagnostic Accuracy of T-SPOT.TB for Active Tuberculosis in Clinical Practice |
| Q63363095 | BCG and protection against Mycobacterium tuberculosis infection |
| Q63363097 | BCG and protection against Mycobacterium tuberculosis infection – Authors' reply |
| Q37757656 | Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice |
| Q34492614 | Boosting of cellular immunity against Mycobacterium tuberculosis and modulation of skin cytokine responses in healthy human volunteers by Mycobacterium bovis BCG substrain Moreau Rio de Janeiro oral vaccine. |
| Q34460809 | Changing approaches to the diagnosis of tuberculosis |
| Q35245278 | Clinical immunology and multiplex biomarkers of human tuberculosis |
| Q46168249 | Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans |
| Q47997569 | Comparative evaluation of ELISA and dot-blot for the diagnosis of tuberculous meningitis |
| Q34189548 | Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak |
| Q37116521 | Comparison of intracellular cytokine flow cytometry and an enzyme immunoassay for evaluation of cellular immune response to active tuberculosis |
| Q36747473 | Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis |
| Q47755861 | Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts |
| Q47279129 | Confirmation of Mycobacterium tuberculosis infection by flow cytometry after ex vivo incubation of peripheral blood T cells with an ESAT-6-derived peptide pool |
| Q39026915 | Construction and immunogenicity of the DNA vaccine of Mycobacterium Tuberculosis dormancy antigen rv1733c |
| Q30391651 | Correlation between tuberculin skin test and IGRAs with risk factors for the spread of infection in close contacts with sputum smear positive in pulmonary tuberculosis. |
| Q38881717 | Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study |
| Q33473026 | Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis |
| Q37626065 | Detection and diagnosis of Mycobacterium tuberculosis |
| Q54102705 | Detection by flow cytometry of ESAT-6- and PPD-specific circulating CD4+ T lymphocytes as a diagnostic tool for tuberculosis. |
| Q34450737 | Determining Mycobacterium tuberculosis infection among BCG-immunised Ugandan children by T-SPOT.TB and tuberculin skin testing |
| Q51025364 | Development of a new DNA vaccine based on mycobacterial ESAT-6 antigen delivered by recombinant invasive Lactococcus lactis FnBPA+. |
| Q35336540 | Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas |
| Q27021614 | Diagnosis and treatment of latent infection with Mycobacterium tuberculosis |
| Q47723579 | Diagnosis of Mycobacterium tuberculosis infection using ESAT-6 and intracellular cytokine cytometry |
| Q22241488 | Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? |
| Q42014010 | Diagnosis of latent tuberculosis: Can we do better? |
| Q63363099 | Diagnosis of tuberculosis |
| Q37302916 | Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-gamma. |
| Q46840144 | Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study |
| Q35834564 | Diagnostic Value of T-Cell Interferon-γ Release Assays on Cerebrospinal Fluid for Tuberculous Meningitis |
| Q38226017 | Diagnostic accuracy of IL-2 for the diagnosis of latent tuberculosis: a systematic review and meta-analysis |
| Q36422684 | Diagnostic value of ex vivo pleural fluid interferon-gamma versus adapted whole-blood quantiferon-TB gold in tube assays in tuberculous pleural effusion |
| Q42413222 | Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation |
| Q58074694 | Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease |
| Q37344826 | Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load |
| Q46493177 | ESAT-6 and CFP-10 can be combined to reduce the cost of testing for Mycobacterium tuberculosis infection, but CFP-10 responses associate with active disease |
| Q42788298 | ESAT-6 and CFP-10: what is the diagnosis? |
| Q46768843 | Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study |
| Q37593534 | Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis |
| Q33769116 | Efficient Ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoids |
| Q51769144 | Enzyme-linked immunospot: an alternative method for the detection of interferon gamma in Johne's disease. |
| Q37426577 | Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection |
| Q87696226 | Evaluation of Treatment Indications, Tuberculin Skin Test, and Bacillus Calmette-Guerin Vaccination Scars in the Cases of Latent Tuberculosis Infection Treatment |
| Q28217959 | Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations |
| Q28714291 | Evaluation of gamma interferon and antibody tuberculosis tests in alpacas |
| Q47340142 | Evaluation of interferon-gamma release assays for the diagnosis of tuberculosis: an updated meta-analysis |
| Q33496134 | Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers |
| Q34525238 | Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population |
| Q33576813 | Evaluation of the prognostic value of IFN-gamma release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal |
| Q57195200 | Ex Vivo Characterization of Early Secretory Antigenic Target 6-Specific T Cells at Sites of Active Disease in Pleural Tuberculosis |
| Q37907518 | Fact and fiction in tuberculosis vaccine research: 10 years later |
| Q41667766 | Feasibility of the interferon-gamma enzyme-linked immunospot assay in chronic renal failure patients and immunocompetent subjects: a head-to-head comparison |
| Q41094226 | Flow cytometry analysis of CD4+IFN-γ+ T-cells for the diagnosis of mycobacterium tuberculosis infection |
| Q36452614 | Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. |
| Q33301317 | Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis |
| Q37418061 | IFN-gamma release assays in tuberculosis management in selected high-risk populations |
| Q33767082 | IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection. |
| Q58924849 | IFN-γ-release assays to diagnose TB infection in the immunocompromised individual |
| Q43466707 | IGRAs--the gateway to T cell based TB diagnosis |
| Q34520629 | Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis. |
| Q92537781 | Immune Biomarkers for Diagnosis and Treatment Monitoring of Tuberculosis: Current Developments and Future Prospects |
| Q33847573 | Immune correlates of acute Mycobacterium tuberculosis infection in household contacts in Kampala, Uganda |
| Q40004825 | Immune response to vaccination with DNA-Hsp65 in a phase I clinical trial with head and neck cancer patients |
| Q36384603 | Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker |
| Q37862987 | Immunological biomarkers of tuberculosis |
| Q33598903 | Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practice |
| Q37386968 | Improved diagnostic evaluation of suspected tuberculosis |
| Q33429956 | In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response |
| Q33662586 | In vivo expression of innate immunity markers in patients with Mycobacterium tuberculosis infection |
| Q35125344 | Increased complement C1q level marks active disease in human tuberculosis. |
| Q45886145 | Influence of previous tuberculin skin test on serial IFN-γ release assays |
| Q35605635 | Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists |
| Q35965052 | Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. |
| Q79716609 | Interferon-gamma gene+874T-A polymorphism is associated with tuberculosis and gamma interferon response |
| Q38168914 | Interferon-gamma release assays for tuberculosis: current and future applications |
| Q58924832 | Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment |
| Q41942801 | Interferon-γ Enzyme-Linked Immunospot Assay in Patients with Tuberculosis and Healthy Adults. |
| Q35629697 | Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study |
| Q33909191 | Kinetics of a tuberculosis-specific gamma interferon release assay in military personnel with a positive tuberculin skin test |
| Q33294711 | Loss of receptor on tuberculin-reactive T-cells marks active pulmonary tuberculosis |
| Q34180893 | Modern laboratory diagnosis of tuberculosis. |
| Q37414160 | New diagnostic methods for tuberculosis |
| Q34527311 | New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis |
| Q30907264 | New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response |
| Q21296755 | Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection |
| Q36184069 | Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children |
| Q81250867 | Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment |
| Q40696371 | Poor agreement between diagnostic tests for latent tuberculosis infection among HIV-infected persons in Hong Kong |
| Q34792863 | Prevalence and Risk Factors for Latent Tuberculosis Infection among Health Care Workers in China: A Cross-Sectional Study |
| Q37314862 | Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact |
| Q90428594 | Progress in interferon-gamma release assay development and applications: an unfolding story of translational research |
| Q36884506 | Progress in serodiagnosis of Mycobacterium tuberculosis infection |
| Q33736323 | Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis |
| Q34299551 | Prospective monitoring reveals dynamic levels of T cell immunity to Mycobacterium tuberculosis in HIV infected individuals |
| Q62801595 | Quels sont les nouveaux outils diagnostiques de la tuberculose ? Quel est leur intérêt pour la prise en charge du malade et quelles sont leurs indications ? |
| Q33854452 | Rapid diagnosis of Mycobacterium tuberculosis meningitis by enumeration of cerebrospinal fluid antigen-specific T-cells. |
| Q53609951 | Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. |
| Q28469137 | Rates of latent tuberculosis in health care staff in Russia |
| Q34628965 | Recent advances in the rapid diagnosis of respiratory tract infection |
| Q34429275 | Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis |
| Q44201389 | Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis |
| Q40500468 | Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic |
| Q42743781 | Repeated tuberculin testing does not induce false positive ELISPOT results |
| Q37844333 | Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development |
| Q42598459 | Risk Factors for Tuberculosis Infection in Children in Contact With Infectious Tuberculosis Cases in The Gambia, West Africa |
| Q46384701 | Risk factors for tuberculosis infection in sub-Saharan Africa: a contact study in The Gambia |
| Q33377580 | School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay |
| Q46845823 | Screening for tuberculosis among 2381 household contacts of sputum-smear-positive cases in The Gambia |
| Q33334644 | Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERONTB Gold with tuberculin skin test |
| Q35024697 | Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis |
| Q64096633 | Secretory Microneme Proteins Induce T-Cell Recall Responses in Mice Chronically Infected with Toxoplasma gondii |
| Q34143564 | Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay |
| Q37157791 | Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infection |
| Q28269807 | Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice |
| Q58924838 | Specific Mycobacterium tuberculosis T cell responses to RD1-selected peptides for the monitoring of anti-tuberculosis therapy |
| Q34781367 | Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection |
| Q34852026 | Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70. |
| Q37237394 | T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis |
| Q43815888 | T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure |
| Q39037917 | T-Spot.TB outperforms tuberculin skin test in predicting development of active tuberculosis among household contacts. |
| Q51146084 | T-Spot.TB outperforms tuberculin skin test in predicting tuberculosis disease. |
| Q33291869 | T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals |
| Q33494752 | T-cell-based diagnosis of tuberculosis infection in children in Lithuania: a country of high incidence despite a high coverage with bacille Calmette-Guerin vaccination |
| Q33187095 | Ten years of research progress and what's to come |
| Q36148582 | Testing for latent tuberculosis |
| Q84775916 | Tests for prediction of active tuberculosis |
| Q34601702 | The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon |
| Q35895230 | The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda |
| Q48290090 | The efficacy of latent tuberculosis treatment for immunocompetent uveitis patients with a positive T-SPOT.TB test: 6-year experience in a tuberculosis endemic region. |
| Q39402027 | The past decade in bench research into pulmonary infectious diseases: What do clinicians need to know? |
| Q36075177 | The pathogenesis of tuberculosis: the first one hundred (and twenty-three) years |
| Q33814812 | The performance and limitation of T-SPOT.TB for the diagnosis of TB in a high prevalence setting |
| Q44374379 | The performance of quantiferon-TB gold in-tube (QFT-IT) test compared to tuberculin skin test (TST) in detecting latent tuberculosis infection (LTBI) in the presence of HIV coinfection in a high TB-burden area with BCG-vaccinated population |
| Q52886952 | The phenotypic distribution and functional profile of tuberculin-specific CD4 T-cells characterizes different stages of TB infection. |
| Q92538932 | Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Identifies Diagnostic Biomarkers That Distinguish Active and Latent Tuberculosis |
| Q84960387 | Tuberculin Skin Test, Interferon-gamma Assay, and T Cells Subpopulations in Hemodialysis Patients |
| Q41414402 | Tuberculin reactivity in first-year schoolchildren in Madagascar |
| Q36238439 | Tuberculosis in neonates and infants: epidemiology, pathogenesis, clinical manifestations, diagnosis, and management issues |
| Q35701685 | Tuberculosis: a problem with persistence |
| Q34516560 | Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study |
| Q33790058 | Use of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing for child tuberculosis contacts |
| Q33477971 | Use of a T cell interferon gamma release assay in the investigation for suspected active tuberculosis in a low prevalence area |
| Q37594933 | Use of antibodies in lymphocyte secretions for detection of subclinical tuberculosis infection in asymptomatic contacts |
| Q30863509 | Use of interferon gamma-based assay to diagnose tuberculosis infection in health care workers after short term exposure |
| Q58277106 | Usefulness of anin-vitrotuberculosis interferon-γ release assay (T-SPOT.TB) in the first-line check-up of uveitis patients |
| Q58877140 | Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TBassay |
| Q21261534 | Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa |
| Q36285657 | Vaccines for tuberculosis: novel concepts and recent progress |
| Q33962683 | Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar |
| Q35033494 | What is Good's syndrome? Immunological abnormalities in patients with thymoma |
| Q43938800 | Whole-blood interferon-gamma assay for the diagnosis of tuberculosis infection in an unselected Greek population |
| Q80059527 | [Interferon-gamma release assays in tuberculosis diagnostics] |
| Q53845781 | [Laboratory diagnosis of mycobacterial infections] |
| Q80237437 | [New blood tests for diagnosis of infection with Mycobacterium tuberculosis] |
| Q53800517 | [New immunological tests in the diagnosis of tuberculosis] |
| Q80519164 | [What examinations are necessary in an exposed, asymptomatic child with a positive tuberculin skin test and normal chest x-ray?] |
Search more.